Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with schizophrenia or schizoaffective disorder according to standard diagnostic guidelines (DSM-5)
- People between the ages of 18 and 60
- People whose treating psychiatrist considers their condition to be currently stable
- People currently taking antipsychotic medication, with no change in their dose in the last 14 days
- People who are able to take part in the consent process, as assessed by a short standardised questionnaire (a score of 10 or more on the Evaluation to Sign Consent)
- People with a Body Mass Index (BMI) of 40 or below (a measure of body weight relative to height)
Who may not be able to join:
- People with gut or digestive conditions — such as Crohn's Disease, Irritable Bowel Syndrome, or Coeliac Disease — where the condition or its treatment could affect schizophrenia symptoms or raise the risks of the study protocol
- People with a brain condition caused by a physical or medical cause, including stroke, epilepsy, traumatic brain injury, or a loss of consciousness lasting more than 30 minutes
- People with an intellectual disability
- People currently taking antibiotics
- People who have received immune therapy within the last three months
- People who have taken prebiotic or probiotic supplements or treatments within the last three months
- People who are unable to understand English
- People who are unable to cooperate with the study procedures
- People who are pregnant or breastfeeding
- People who meet standard diagnostic criteria (DSM-5) for alcohol or substance misuse (other than caffeine or nicotine) within the last three months — note that people with mild marijuana misuse as defined by DSM-5 criteria may still be considered eligible (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Robert Buchanan, M.D., University of Maryland, Baltimore
Phone: 410-402-6411
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in serum butyrate levels; Cognition; Incidence of Side Effects
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.